Nitric Oxide Releasing Solution to Treat and Prevent Exacerbation of Mild COVID-19 Infection

NCT04443868 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped No subjects enrolled

Conditions

SARS-CoV Infection

Interventions

DRUG: Nitric Oxide-Releasing Drug

Sponsor

Sanotize Research and Development corp.